{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:34:52Z","timestamp":1775540092113,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1073,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/ane.12012","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T01:57:06Z","timestamp":1348451826000},"page":"e8-e12","source":"Crossref","is-referenced-by-count":19,"title":["Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies"],"prefix":"10.1155","volume":"127","author":[{"given":"R.","family":"Constantinescu","sequence":"first","affiliation":[{"name":"Department of Neurology; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Andreasson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Holmberg","sequence":"additional","affiliation":[{"name":"Department of Neurology; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology; The Sahlgrenska Academy; University of Gothenburg; Gothenburg; Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,9,23]]},"reference":[{"issue":"10 Suppl 3","key":"10.1111\/ane.12012-BIB0001|ane12012-cit-0001","first-page":"32","article-title":"Oxidation reactions in Parkinson's disease","volume":"40","author":"Olanow","year":"1990","journal-title":"Neurology"},{"key":"10.1111\/ane.12012-BIB0002|ane12012-cit-0002","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/oxfordjournals.aje.a008954","article-title":"Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease","volume":"144","author":"Davis","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1111\/ane.12012-BIB0003|ane12012-cit-0003","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.21502","article-title":"Low plasma uric acid level in Parkinson's disease","volume":"22","author":"Annanmaki","year":"2007","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12012-BIB0004|ane12012-cit-0004","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/aje\/kwm385","article-title":"Diet, urate, and Parkinson's disease risk in men","volume":"167","author":"Gao","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1111\/ane.12012-BIB0005|ane12012-cit-0005","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/art.24193","article-title":"Gout and the risk of Parkinson's disease: a cohort study","volume":"59","author":"De Vera","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/ane.12012-BIB0006|ane12012-cit-0006","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","article-title":"Urate as a predictor of the rate of clinical decline in Parkinson disease","volume":"66","author":"Ascherio","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12012-BIB0007|ane12012-cit-0007","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.parkreldis.2007.11.001","article-title":"Uric acid associates with cognition in Parkinson's disease","volume":"14","author":"Annanmaki","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12012-BIB0008|ane12012-cit-0008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2011-110587","article-title":"Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-beta pathway","volume":"27","author":"Maetzler","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1111\/ane.12012-BIB0009|ane12012-cit-0009","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/mds.23556","article-title":"Uric acid as a potential disease modifier in patients with multiple system atrophy","volume":"26","author":"Lee","year":"2011","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12012-BIB0010|ane12012-cit-0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.22907","article-title":"The relationship between uric acid levels and Huntington's disease progression","volume":"25","author":"Auinger","year":"2010","journal-title":"Mov Disord"},{"issue":"Pt 2","key":"10.1111\/ane.12012-BIB0011|ane12012-cit-0011","first-page":"377","article-title":"Serum uric acid and cognitive function and dementia","volume":"132","author":"Euser","year":"2009","journal-title":"Brain"},{"key":"10.1111\/ane.12012-BIB0012|ane12012-cit-0012","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12012-BIB0013|ane12012-cit-0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02309628","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"8","author":"Gilman","year":"1998","journal-title":"Clin Auton Res"},{"key":"10.1111\/ane.12012-BIB0014|ane12012-cit-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1111\/ane.12012-BIB0015|ane12012-cit-0015","first-page":"877","volume-title":"Neurodegenerative diseases","author":"Lang","year":"1994"},{"key":"10.1111\/ane.12012-BIB0016|ane12012-cit-0016","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1111\/ane.12012-BIB0017|ane12012-cit-0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson's disease","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12012-BIB0018|ane12012-cit-0018","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00019052-199908000-00011","article-title":"Recent advances in atypical parkinsonian disorders","volume":"12","author":"Litvan","year":"1999","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 6","key":"10.1111\/ane.12012-BIB0019|ane12012-cit-0019","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12012-BIB0020|ane12012-cit-0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.870130116","article-title":"Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease","volume":"13","author":"Holmberg","year":"1998","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12012-BIB0021|ane12012-cit-0021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2008.05.012","article-title":"Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease","volume":"15","author":"Constantinescu","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12012-BIB0022|ane12012-cit-0022","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03009738809178548","article-title":"Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid","volume":"93","author":"Niklasson","year":"1988","journal-title":"Ups J Med Sci"},{"key":"10.1111\/ane.12012-BIB0023|ane12012-cit-0023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(90)90281-F","article-title":"Uric acid levels and dopamine transmission in rat striatum: diurnal changes and effects of drugs","volume":"507","author":"O'Neill","year":"1990","journal-title":"Brain Res"},{"key":"10.1111\/ane.12012-BIB0024|ane12012-cit-0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-3565(25)33291-X","article-title":"Effect of L-dopa on renal handling of uric acid","volume":"223","author":"Bierer","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/ane.12012-BIB0025|ane12012-cit-0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/aje\/kwp033","article-title":"Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study","volume":"169","author":"Chen","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1111\/ane.12012-BIB0026|ane12012-cit-0026","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.23070","article-title":"Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey","volume":"25","author":"Winquist","year":"2010","journal-title":"Mov Disord"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12012","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12012\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:20:33Z","timestamp":1744186833000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,23]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12012","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,23]]}}}